Autonomix Medical wins Canadian patent for catheter-based transvascular nerve therapy platform
AMIX•Autonomix Medical received a Canadian patent covering catheter-based transvascular tools that access tissue beyond blood vessel walls. Its portfolio now totals 112 issued or pending patent applications worldwide, with related patents issued in the United States and Europe.
1. Patent coverage
The Canadian patent covers catheter-based transvascular tools that access tissue beyond blood vessel walls. Autonomix said the protection supports its platform for precision nerve-targeted therapies, including real-time physiological feedback to guide delivery and confirm effect.
2. Patent portfolio
The company said its portfolio totals 112 issued or pending patent applications worldwide. Related patents have already been issued in the United States and Europe.
